Concepedia

Cuicui Lyu

CL

14

Publications

534

Citations

13

H-Index

2015

Active since

Affiliations

Tianjin Medical University(Current)

Tianjin First Center Hospital

Institute of Hematology & Blood Diseases Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Nankai University

Cuicui Lyu is an author at Tianjin Medical University specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2015–2024

14

Publications

14

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Yaqing Cao, Wenyi Lu, Rui Sun et al. · Frontiers in Oncology · 2019 · 152 citations · Full text

, , +15

Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system

Cuicui Lyu, Jun Shen, Rui Wang et al. · Stem Cell Research & Therapy · 2018 · 102 citations · Full text

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant

Pengjiang Liu, Meijing Liu, Cuicui Lyu et al. · Frontiers in Oncology · 2020 · 57 citations · Full text

Vitronectin‐activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells

Jun Shen, Yaoyao Zhu, Shuo Zhang et al. · Cell Proliferation · 2021 · 36 citations · Full text

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

Yifan Zhao, Xiaomei Zhang, Meng Zhang et al. · Annals of Hematology · 2024 · 27 citations

, , +15

Rows per page

1–5 of 14